Your browser doesn't support javascript.
loading
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki, Kohjiro; Sasako, Takayoshi; Okazaki, Yukiko; Kato, Masayuki; Okahata, Sumie; Katsuyama, Hisayuki; Haraguchi, Mikiko; Morita, Ai; Ohashi, Ken; Hara, Kazuo; Morise, Atsushi; Izumi, Kazuo; Ishizuka, Naoki; Ohashi, Yasuo; Noda, Mitsuhiko; Kadowaki, Takashi.
Afiliação
  • Ueki K; Department of Molecular Diabetic Medicine, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Sasako T; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Translational Systems Biology and Medicine Initiative, The University of Tokyo, Tokyo, Japan.
  • Okazaki Y; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kato M; Health Management Center and Diagnostic Imaging Center, Toranomon Hospital, Tokyo, Japan.
  • Okahata S; Division of Diabetes and Metabolism, Toho University Ohashi Medical Center, Tokyo, Japan.
  • Katsuyama H; Department of Internal Medicine, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan.
  • Haraguchi M; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Morita A; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ohashi K; Department of General Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.
  • Hara K; Department of Endocrinology and Metabolism, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Morise A; Department of Internal Medicine, Tokyo Takanawa Hospital, Tokyo, Japan.
  • Izumi K; Department of Clinical Research Strategic Planning, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ishizuka N; Clinical Research Center, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
  • Noda M; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
  • Kadowaki T; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Translational Systems Biology and Medicine Initiative, The University of Tokyo, Tokyo, Japan. Electronic address: kadowaki-3im@h.u-tokyo.ac.jp.
Lancet Diabetes Endocrinol ; 5(12): 951-964, 2017 12.
Article em En | MEDLINE | ID: mdl-29079252
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Intervenção Médica Precoce Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Intervenção Médica Precoce Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido